An Open-label, Randomized, 2-Period, Crossover, Pharmacokinetics Study
Clinical trial NCT05360576 · COMPLETED
Trial details
- NCT number
- NCT05360576
- Sponsor
- Lupin Research Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-24
- Primary completion
- 2022-07-04
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.